five

Supplementary materials for A Phase III Study to Compare Efficacy and Safety of BAT2206 (Proposed Ustekinumab Biosimilar) with Reference Ustekinumab in Patients with Moderate to Severe Plaque Psoriasis

收藏
DataCite Commons2025-04-01 更新2025-04-16 收录
下载链接:
https://data.mendeley.com/datasets/w2vksw3xdd
下载链接
链接失效反馈
官方服务:
资源简介:
Supplementary tables
提供机构:
Mendeley Data
创建时间:
2024-11-13
二维码
社区交流群
二维码
科研交流群
商业服务